High density lipoproteins and atherosclerosis: emerging aspects
- PMID: 23341845
- PMCID: PMC3545258
- DOI: 10.3724/SP.J.1263.2011.12282
High density lipoproteins and atherosclerosis: emerging aspects
Abstract
High density lipoproteins (HDL) promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion. This ability is responsible for the most relevant anti-atherogenic effect of HDL. The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. Furthermore, during inflammation, the composition of this class of lipoproteins varies to a large extent, thus promoting the formation of dysfunctional HDL. The aim of this review is to discuss the emerging role of HDL in modulating the activity of immune cells and immune-inflammatory mediators during atherogenesis.
Keywords: Apolipoprotein; High density lipoproteins; Immune response; Sphingosine-1-phosphate.
References
-
- Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104:503–516. - PubMed
-
- Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204–212. - PubMed
-
- Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004;45:993–1007. - PubMed
-
- von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:13–27. Role of cholesterol efflux and reverse cholesterol transport. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources